首页> 外文期刊>Contraception >Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.
【24h】

Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.

机译:修改世界卫生组织的避孕药具资格标准,以用于美国。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The Centers for Disease Control and Prevention (CDC) recently adapted global guidance on contraceptive use from the World Health Organization (WHO) to create the United States Medical Eligibility Criteria for Contraceptive Use (MEC). This guidance includes recommendations for use of specific contraceptive methods by people with certain characteristics or medical conditions. STUDY DESIGN: CDC determined the need and scope for the adaptation, conducted 12 systematic reviews of the scientific evidence and convened a meeting of health professionals to discuss recommendations based on the evidence. RESULTS: The vast majority of the US guidance is the same as the WHO guidance and addresses over 160 characteristics or medical conditions. Modifications were made to WHO recommendations for six medical conditions, and recommendations were developed for six new medical conditions. CONCLUSION: The US MEC is intended to serve as a source of clinical guidance for providers as they counsel clients about contraceptive method choices.
机译:背景:疾病控制和预防中心(CDC)最近改编了世界卫生组织(WHO)提供的关于避孕药具使用的全球指南,以制定美国避孕药具医疗资格标准(MEC)。本指南包括对具有某些特征或医疗状况的人使用特定避孕方法的建议。研究设计:疾病预防控制中心确定了适应的需求和范围,对科学证据进行了12次系统审查,并召开了卫生专业人员会议,以讨论基于证据的建议。结果:美国绝大多数指南与WHO指南相同,涉及160多种特征或医疗状况。对世卫组织关于六种医疗状况的建议进行了修改,并针对六种新的医疗状况制定了建议。结论:US MEC旨在为医疗服务提供者提供临床指导,为他们提供有关避孕方法选择的咨询服务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号